The landscape of dementia analysis has advanced radically with the arrival of innovative biomarkers, like amyloid PET scans, tau imaging, and blood-based mostly tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. While these technological innovations depict exceptional progress in being familiar with neurodegenerative conditions, https://fredericj318dnx7.blogadvize.com/profile